Fig. 2

Survival analysis and the prognostic value of YKL-39, CD68 and CD34 expression in patients with GC. Kaplan–Meier survival curves of A YKL-39, B CD68, C CD34 expression in GC patients. D Kaplan-Meier survival curves of OS among the four patient groups stratified by YKL-39 and CD68 expression. E Kaplan-Meier survival curves of OS among four patient groups stratified by YKL-39 and CD34 expression. F Results of univariate COX regression analysis of YKL-39, CD68, CD34 expression, and clinicopathological information. G Results of multivariate COX regression analysis of YKL-39, CD68, CD34 expression, and clinicopathological information